RIP140 deficiency enhances cardiac fuel metabolism and protects mice from heart failure
Tsunehisa Yamamoto(Bristol-Myers Squibb (Japan)), Daniel P. Kelly(Cardiovascular Institute of the South), Kirill Batmanov(University of Pennsylvania), Pieterjan Dierickx(University of Pennsylvania), Elizabeth Pruzinsky(University of Pennsylvania), Ling‐Ping Lai(National Taiwan University Hospital), Sarah M. Sulon(University of Pennsylvania), Tomoya Sakamoto(University of Pennsylvania), Kendra S. McDaid(University of Pennsylvania), Mitchell A. Lazar(University of Pennsylvania), Deborah M. Muoio(Duke University), Yang Xiao(Memorial Sloan Kettering Cancer Center), E. Douglas Lewandowski, Yang Wang(The Ohio State University), Santosh K. Maurya(The Ohio State University), Swapnil V. Shewale(University of Pennsylvania), Teresa C. Leone(Cardiovascular Institute of the South), Timothy R. Koves(Duke University)
Cited by 19
Related Papers
Peroxisome proliferator–activated receptor γ coactivator-1 promotes cardiac mitochondrial biogenesis
|Journal of Clinical Investigation|2000|1.3k
PGC-1α Deficiency Causes Multi-System Energy Metabolic Derangements: Muscle Dysfunction, Abnormal Weight Control and Hepatic Steatosis
|PLoS Biology|2005|942
A critical role for the peroxisome proliferator-activated receptor α (PPARα) in the cellular fasting response: The PPARα-null mouse as a model of fatty acid oxidation disorders
|Proceedings of the National Academy of Sciences|1999|940
CAR T Cells Produced in vivo to Treat Cardiac Injury
|HAL (Le Centre pour la Communication Scientifique Directe)|2023|940
The cardiac phenotype induced by PPARα overexpression mimics that caused by diabetes mellitus
|Journal of Clinical Investigation|2002|879